Trial no.:
|
PACTR202110484536189 |
Date of Approval:
|
29/10/2021 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Adaptation and pilot evaluation of Problem Management Plus Intervention(PM+) to address psychological distress caused by Covid-19 and other adversities amongst an amaXhosa sample in the Eastern Cape, South Africa |
Official scientific title |
Adaptation and pilot evaluation of Problem Management Plus Intervention(PM+) to address psychological distress caused by Covid-19 and other adversities amongst an amaXhosa sample in the Eastern Cape, South Africa |
Brief summary describing the background
and objectives of the trial
|
WHO has developed Problem Management Plus (PM+), which is aimed to reduce symptoms of psychological distress (anxiety, depression, posttraumatic stress disorder) among communities affected by trauma and adversities. PM+ consists of 5 sessions of evidence based psychotherapeutical techniques (cognitive behavioural therapy and problem solving therapy), and can be delivered by non-professional counsellors. PM+ has been widely studied ( Bryant et al., 2017), but no studies have yet adapted or evaluated PM+ for the Xhosa community. PM+ has the potential to create more access to psychological services in South Africa because it can be conducted by lay helpers at no cost for the client. The Objectives are: 1) To evaluate the feasibility, acceptability and preliminary effects of the culturally and contextually adapted PM+ within the Xhosa community during the COVID-19 pandemic in terms of mental health outcomes and day-to-day functioning 2) To identify barriers and facilitators to treatment engagement and adherence and opportunities for scaling up PM+ among the Xhosa community in South Africa |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Common mental disorders |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Psychosocial |
Anticipated trial start date |
01/06/2023 |
Actual trial start date |
01/06/2023 |
Anticipated date of last follow up |
01/07/2023 |
Actual Last follow-up date |
01/08/2023 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
100 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|